Stock AXDX ACCELERATE DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Real-time Estimate Cboe BZX
Other stock markets
 03:55:14 2024-07-09 pm EDT 		5-day change 1st Jan Change
1.145 USD -2.14% Intraday chart for Accelerate Diagnostics, Inc. 0.00% -70.66%
May. 20 Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust CI
May. 08 Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M MT

Evolution of the average Target Price on Accelerate Diagnostics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

44b276d72498ed82182d8435d09.mvsq96FeyXtJlrxvIl-GfSWMaXJkcRc3LDOyHej_K2w.479Ous0zhUkLw_s5bC3CNV3_CC02XE8PWEWEb7--bCbRnx2i4hWxKSzb1w~8877adc0d0b62fe391be7e7c656f5b69

Analyst Recommendations on Accelerate Diagnostics, Inc.

Craig Hallum Cuts Accelerate Diagnostics Price Target to $0.60 From $2, Maintains Hold Rating MT
Craig-Hallum Downgrades Accelerate Diagnostics to Hold From Buy; Price Target is $5 MT
Craig-Hallum Adjusts Accelerate Diagnostics' Price Target to $9 from $12, Maintains Buy Rating MT
ACCELERATE DIAGNOSTICS : Piper Sandler Adjusts Price Target on Accelerate Diagnostics to $9 From $12, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.17
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering Accelerate Diagnostics, Inc.

Craig-Hallum

Ratings for Accelerate Diagnostics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AXDX Stock
  4. Consensus Accelerate Diagnostics, Inc.